Table 1.
Demographical and clinical characteristics of the enrolled subjects.
| COVID-19 | NO COVID-19 | P value | |
|---|---|---|---|
| N (%) | 39 | 19 | |
| Age median (IQR) | 57 (42–76) | 49 (38–54) | 0.04 |
| Male N (%) | 18 (46.2) | 8 (42.1) | 0.77 |
| Origin N (%) | |||
| Western Europe | 22 (56.4) | 13 (68.4) | 0.54 |
| Eastern Europe | 1 (2.6) | 1 (5.3) | |
| Asia | 12 (30.8) | 2 (10.5) | |
| Africa | 3 (7.7) | 2 (10.5) | |
| North America | 0 (0) | 0 | |
| South America | 1 (2.6) | 1 (5.3) | |
| Swab positive results N (%)* | 39 (100) | 0 (0) | <0.0001 |
| Serology positive results N (%)§ | 21 (63.6) | 0 (0) | <0.0001 |
| Severity N (%) | |||
| mild | 12 (30.8) | – | |
| moderate | 16 (41.0) | – | |
| severe | 3 (7.7) | – | |
| critical | 8 (20.5) | – | |
Footnotes: COVID-19: COronaVIrus Disease 19; N: Number;* info available for 39 COVID-19 (100%) and 7 “NO COVID-19″ (36.8%) individuals. § info available from 33 COVID-19 (84.6%) and 19 “NO COVID-19″ (100%) individuals.